Print

Arrowhead Research Corporation (ARWR) Prices At-Market Private Offering for $60 Million Net Proceeds  
10/8/2013 10:01:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it has priced a private offering with net proceeds expected to be $60 million. The offering was priced at $5.86 per share of common stock.

Help employers find you! Check out all the jobs and post your resume.

//-->